Simplex Trading
RNAM

Simplex Trading’s Avidity Biosciences RNAM Stock Holding History

Simplex Trading’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,607
Closed -$2.78M – 9984
2025
Q4 		$2.78M Sell
38,607
-6,291
-14% -$406K ﹤0.01% 1714
2025
Q3 		$1.96M Buy
44,898
+42,002
+1,450% +$1.7M ﹤0.01% 2347
2025
Q2 		$82K Buy
+2,896
New +$86.3K ﹤0.01% 5431
2024
Q3 		– Sell
-8,703
Closed -$378K – 9413
2024
Q2 		$355K Sell
8,703
-2,303
-21% -$66.1K ﹤0.01% 4036
2024
Q1 		$280K Buy
+11,006
New +$172K ﹤0.01% 4484
2023
Q3 		– Sell
-11,972
Closed -$103K – 9647
2023
Q2 		$132K Buy
11,972
+2,725
+29% +$34.2K ﹤0.01% 4754
2023
Q1 		$141K Buy
9,247
+7,941
+608% +$175K ﹤0.01% 4754
2022
Q4 		$28K Buy
1,306
+1,174
+889% +$17.5K ﹤0.01% 6555
2022
Q3 		$2K Buy
+132
New +$2.52K ﹤0.01% 9343
2022
Q1 		– Sell
-88
Closed -$1.5K – 11244
2021
Q4 		$2K Buy
+88
New +$2.1K ﹤0.01% 10043

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Simplex Trading's RNAM Position: Q1 2026 in Review

Simplex Trading sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 38,607 shares — an estimated $2.78M sold.

Simplex Trading first reported a position in RNAM in Q4 2021 and held it in 10 quarters. The position peaked at $2.78M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Simplex Trading reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 38,607 Avidity Biosciences shares in Q1 2026, an estimated $2.78M.
  • Simplex Trading first reported a position in Avidity Biosciences in Q4 2021 and held it in 10 quarters.
  • Simplex Trading's Avidity Biosciences position peaked at $2.78M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.